Treatment for Nasal Cellulitis with Prior MRSA History
Given the history of MRSA colonization and facial location (difficult to drain area), you should prescribe oral antibiotics with MRSA coverage: either clindamycin 300-450 mg three times daily OR trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily for 5-10 days, PLUS intranasal mupirocin 2% ointment twice daily for 5 days to address the nasal colonization. 1
Why MRSA Coverage is Critical Here
The nose is explicitly identified as a "difficult to drain" area requiring antibiotic therapy even for abscesses 1. Your patient has two key risk factors that mandate empirical MRSA coverage:
- Prior MRSA colonization history - This patient is at high risk for MRSA infection
- Facial/nasal location - The guidelines specifically list "face" as an area requiring antibiotic therapy due to difficulty draining 1
The IDSA guidelines recommend empirical CA-MRSA coverage for purulent cellulitis, and given the nasal involvement with prior MRSA history, treating this as potentially purulent/MRSA-related is prudent 1.
Oral Antibiotic Options for MRSA Coverage
First-line choices (pick ONE):
- Clindamycin 300-450 mg PO three times daily - Covers both MRSA and streptococci, so monotherapy is adequate 1
- TMP-SMX 1-2 double-strength tablets twice daily PLUS amoxicillin 500 mg three times daily - TMP-SMX covers MRSA but not streptococci, so add beta-lactam for strep coverage 1
- Doxycycline 100 mg twice daily PLUS amoxicillin 500 mg three times daily - Alternative if above unavailable 1
Duration: 5-10 days, individualized based on clinical response 1
Intranasal Decolonization is Essential
Add intranasal mupirocin 2% ointment applied to both nostrils twice daily for 5 days. 2, 3, 4, 5
This addresses the MRSA colonization inside the nose and reduces infection risk. Studies show mupirocin combined with systemic antibiotics achieves 74% eradication at 3 months in MRSA carriers 2. For nasal infections specifically, decolonization is both therapeutic and preventive 3, 4.
Critical Pitfalls to Avoid
Do NOT use TMP-SMX or doxycycline as monotherapy - These lack streptococcal coverage, which remains important even with MRSA history. You must add a beta-lactam like amoxicillin if choosing these agents 1.
Do NOT use rifampin - Either alone or as adjunctive therapy for skin infections 1.
Timing matters for mupirocin - If you obtain nasal cultures, collect them BEFORE starting mupirocin, as prior mupirocin use may reduce the negative predictive value of MRSA screens 6.
When to Obtain Cultures
Obtain nasal cultures if:
- Severe local infection or systemic signs
- Patient fails to respond to initial therapy within 48-72 hours
- You need to confirm MRSA and check susceptibilities (especially clindamycin resistance) 1
Culture results will guide whether to continue, narrow, or broaden therapy.
If Patient Requires Hospitalization
If the cellulitis is extensive, rapidly progressive, or the patient has systemic toxicity, hospitalization with IV antibiotics is warranted. Options include:
- IV vancomycin (dose based on weight and renal function)
- IV linezolid 600 mg twice daily
- IV clindamycin 600 mg three times daily (if local resistance <10%) 1
The facial location and prior MRSA history lower your threshold for admission if there's any concern about progression.